| Alton Etheridge |
eth******@goodtherapeutics.com
|
goodtherapeutics.com |
Scientist |
|
Seattle, Washington, United States |
|
| Hyam Levitsky |
hya**********@junotherapeutics.com
|
Juno Therapeutics, Inc. |
Executive Vice President Research, Chief Scientific Officer |
Biotechnology |
Seattle, Washington, United States |
|
| Bill Donahue |
bil*********@junotherapeutics.com
|
Juno Therapeutics, Inc. |
Head of Sequencing |
Biotechnology |
Seattle, WA, US |
|
| Lothar Germeroth |
lot*************@junotherapeutics.com
|
Juno Therapeutics, Inc. |
SVP, Managing Director Juno Therapeutics GmbH |
Biotechnology |
Göttingen, NDS, DE |
|
| Lauren Ross |
lau********@junotherapeutics.com
|
Juno Therapeutics, Inc. |
Associate Director, Strategic Sourcing and External Manufacturing, Cell Therapy |
Biotechnology |
California, United States |
|
| Bob Melkerson |
bob**********@junotherapeutics.com
|
Juno Therapeutics, Inc. |
Director IT, Business Applications |
Biotechnology |
Seattle, WA, US |
|
| Ken Weese |
ken******@junotherapeutics.com
|
Juno Therapeutics, Inc. |
Associate Director, Cell Therapy External Manufacturing and Strategic Sourcing |
Biotechnology |
Seattle, WA, US |
|
| Gerard Casavant |
ger************@junotherapeutics.com
|
Juno Therapeutics, Inc. |
|
Biotechnology |
Poulsbo, WA, US |
|
| Robert Habib |
rob***@minatx.com
|
minatx.com |
CEO |
|
London, GB |
|
| Matthew C |
mat****@minatx.com
|
minatx.com |
Research Director |
|
Barton-upon-Humber, GB |
|